Stonebridge Capital Advisors LLC Merck & Co., Inc. Transaction History
Stonebridge Capital Advisors LLC
- $1.19 Billion
- Q3 2024
A detailed history of Stonebridge Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stonebridge Capital Advisors LLC holds 144,367 shares of MRK stock, worth $12.6 Million. This represents 1.37% of its overall portfolio holdings.
Number of Shares
144,367
Previous 136,755
5.57%
Holding current value
$12.6 Million
Previous $16.9 Million
3.17%
% of portfolio
1.37%
Previous 1.5%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,859Shares Held
1.89BCall Options Held
15.6MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA250MShares$21.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.62 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.16 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $221B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...